86 results
Page 2 of 5
8-K
EX-99.1
dga3 60w6v9
22 Jun 22
Athira Pharma Announces Topline Results from ACT-AD Phase 2 Proof of Concept Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease
7:05am
8-K
EX-99.2
t4tf15a
22 Jun 22
Athira Pharma Announces Topline Results from ACT-AD Phase 2 Proof of Concept Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease
7:05am
8-K
EX-99.1
f4iwelzprpw 8ir5x
12 May 22
Athira Pharma Reports First Quarter 2022 Financial Results
4:12pm
DEFA14A
r2hp nif41if5
11 May 22
Additional proxy soliciting materials
4:49pm
DEFA14A
ko5sojsyl
9 May 22
Additional proxy soliciting materials
4:32pm
DFAN14A
EX-99.1
1zr57a8
5 May 22
Additional proxy materials by non-management
11:00am
DFAN14A
EX-99.1
6jp5ie5yz1x
27 Apr 22
Additional proxy materials by non-management
2:39pm
DFAN14A
EX-99.1
ufrk864ehsk1mnu ur6l
25 Apr 22
Additional proxy materials by non-management
3:31pm
DFAN14A
EX-99.3
1xf tc8ehx
22 Apr 22
Additional proxy materials by non-management
10:07am
DEFA14A
mu7ktz wsfx7
11 Apr 22
Additional proxy soliciting materials
4:36pm
DEFC14A
c0401g2h lwoco5
11 Apr 22
Proxy in contested solicitation
8:36am
PREC14A
ca5a7v umvr8vsyf
8 Apr 22
Preliminary proxy with contested solicitation
4:21pm
DEFC14A
mfdj5q
5 Apr 22
Proxy in contested solicitation
4:08pm
PREC14A
w7yfbn1dq eva
30 Mar 22
Preliminary proxy with contested solicitation
5:23pm
DFAN14A
s1mc59wo4n3xhp9
30 Mar 22
Additional proxy materials by non-management
10:21am
PREC14A
tzb0z mrm
25 Mar 22
Preliminary proxy with contested solicitation
5:15pm
8-K
EX-99.1
jz2b3zps
24 Mar 22
Athira Pharma Reports Full Year 2021 Financial Results and Provides Clinical Update
4:11pm